5-Amino-1MQ vs BI 456906

Head-to-head comparison of 5-Amino-1MQ (5-Amino-1-methylquinolinium) and BI 456906 (BI 456906, glucagon-like peptide-1/glucagon receptor dual agonist) — benefits, dosing, side effects, research data, and where to buy.

Research Score

Property5-Amino-1MQBI 456906
CategoryWeight ManagementWeight Management
Full Name5-Amino-1-methylquinoliniumBI 456906, glucagon-like peptide-1/glucagon receptor dual agonist
Molecular Weight178.23 g/molN/A
Half-Life~6 hoursApproximately 1 week
Amino AcidsSmall moleculeN/A
Typical DoseTrial-dependent; weekly SC dosing
RouteSubcutaneous
Purity>98%≥98%
Studies Count2810
Research StatusActive ResearchClinical

5-Amino-1MQ Benefits

  • Reduces body fat without appetite changes, lowers cholesterol, increases NAD+ levels, improves metabolic efficiency, supports cellular energy production

BI 456906 Benefits

  • weight reduction
  • improved glucose control
  • lower liver-fat burden
  • enhanced satiety

5-Amino-1MQ Dosing

Research doses: 50-150 mg orally daily. Often cycled 8-12 weeks on, 4 weeks off. Best taken in the morning.

BI 456906 Dosing

once-weekly subcutaneous injection|stepwise titration|ongoing maintenance phase

5-Amino-1MQ Side Effects

  • Generally well-tolerated in preclinical models. Potential mild GI discomfort and headache. Long-term human safety data is limited.

BI 456906 Side Effects

  • nausea
  • abdominal discomfort
  • diarrhea

Research Overview

5-Amino-1MQ

Studies in diet-induced obese mice showed significant reductions in body weight, white adipose tissue mass, and cholesterol levels without changes in food intake. Works by inhibiting NNMT enzyme to increase NAD+ and activate sirtuins.

BI 456906

Preclinical and early clinical research support meaningful metabolic effects with a tolerable safety profile. It remains investigational and is not commercially available.

Ready to buy?

Find both peptides from our verified, lab-tested vendors with purity certificates and third-party testing.

Common Stacking Partners

5-Amino-1MQ stacks with:

AOD-9604MOTS-cCJC-1295

BI 456906 stacks with:

metforminbupropion
weight-lossNNMT-inhibitorfat-lossmetabolismNAD+glp1glucagondual-agonistmetabolic-disease